Overview ACCURATE Study for Subjects With Dry Eyes Status: Recruiting Trial end date: 2021-12-30 Target enrollment: Participant gender: Summary To determine treatment and imaging outcomes in bilateral ocular surface disease management with an intracanalicular dexamethasone (0.4 mg) insert compared to standard topical over-the-counter artificial tears lubrication management Phase: Phase 4 Details Lead Sponsor: The Eye Centers of Racine and KenoshaTreatments: BB 1101DexamethasoneDexamethasone acetateLubricant Eye Drops